Aura Biosciences (AURA) stock: insider trades, news & valuation
Heavy sellingShare price and insider trades
Aura Biosciences insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 7 sold $40.1M of AURA stock on the open market.
Get emailed when insiders cluster-buy stocks like AURA
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
AURA insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | $39.2M | 3 |
| Q1 2026 | — | 0 | $619K | 7 |
| Q4 2025 | — | 0 | $233K | 4 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 Aura Biosciences, Inc. insiders reported open-market purchases totaling $0, while 7 insiders reported sales totaling $40.1M. 0 of 14 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Jun 16SEC | Anthony S GibneySee Remarks | Sell | 12,824265,354 held (−5%) | $6.42 | $82K | +1.9% | — |
| May 11SEC | Matrix Capital Management Company, Lp10% Owner | Sell | 6,922,870 | $5.64 | $39.0M | +16.0% | — |
| Apr 16SEC | Conor KilroySee Remarks | Sell | 11,738217,835 held (−5%) | $7.02 | $82K | -6.8% | — |
| Feb 17SEC | Los Pinos Elisabet DeSee Remarks | Sell | 47,648409,815 held (−10%) | $5.06 | $241K | +29.2% | — |
| Feb 17SEC | Janet Jill HopkinsChief Medical Officer | Sell | 20,401232,284 held (−8%) | $5.06 | $103K | +29.2% | — |
| Feb 17SEC | Mark PlavsicCTO | Sell | 15,890181,397 held (−8%) | $5.05 | $80K | +29.5% | — |
| Feb 17SEC | Conor KilroySee Remarks | Sell | 12,079167,234 held (−7%) | $5.05 | $61K | +29.5% | — |
| Feb 17SEC | Amy ElazzouziPresident | Sell | 8,54975,532 held (−10%) | $5.06 | $43K | +29.2% | — |
| Jan 20SEC | Los Pinos Elisabet DeSee Remarks | Sell | 16,928457,463 held (−4%) | $4.86 | $82K | +34.6% | — |
| Jan 20SEC | Amy ElazzouziPresident | Sell | 1,58184,081 held (−2%) | $4.86 | $8K | +34.6% | — |
| Nov 17SEC | Janet Jill HopkinsChief Medical Officer | Sell | 17,109252,685 held (−6%) | $5.42 | $93K | +20.7% | — |
| Oct 29SEC | Los Pinos Elisabet DeSee Remarks | Sell | 9,049474,391 held (−2%) | $6.35 | $57K | +3.0% | — |
| Oct 29SEC | Amy ElazzouziPresident | Sell | 89685,662 held (−1%) | $6.35 | $6K | +3.0% | — |
| Oct 16SEC | Mark PlavsicCTO | Sell | 12,169197,287 held (−6%) | $6.35 | $77K | +3.0% | — |
Insiders at Aura Biosciences, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Matrix Capital Management Company, Lp10% Owner | — | $39.0M | May 11, 2026 | — |
| Los Pinos Elisabet DeSee Remarks | — | $381K | Feb 17, 2026 | — |
| Janet Jill HopkinsChief Medical Officer | — | $196K | Feb 17, 2026 | — |
| Mark PlavsicCTO | — | $158K | Feb 17, 2026 | — |
| Conor KilroySee Remarks | — | $143K | Apr 16, 2026 | — |
| Anthony S GibneySee Remarks | — | $82K | Jun 16, 2026 | — |
| Amy ElazzouziPresident | — | $57K | Feb 17, 2026 | — |
AURA stock: common questions
Are Aura Biosciences, Inc. insiders buying AURA stock?
In the past 12 months, 0 insiders reported open-market purchases of AURA worth $0.
Are Aura Biosciences, Inc. insiders selling AURA stock?
7 insiders reported sales worth $40.1M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is AURA's 52-week range?
Over the past year AURA has traded between $4.97 and $8.90. It last closed at $6.54 on Oct 9, 2026.